Exploring the anticancer potential of new 3‐cyanopyridine derivatives bearing N‐acylhydrazone motif: Synthesis, DFT calculations, cytotoxic evaluation, molecular modeling, and antioxidant properties
Journal of Biochemical and Molecular Toxicology · 2024
DOI: 10.1002/jbt.23819 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2024. Verfasst von Ibtissem Kadi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Synthesis of Molecules with Biological Interest, University of Constantine 1, Constantine, Algeria. Hauptthemen laut MEDLINE: Antineoplastic Agents, Hydrazones, Pyridines, Antioxidants. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
3‐Cyanopyridine derivatives are known for exhibiting excellent anticancer activity due to their strong capability to inhibit various biological targets, including Pim‐1 kinase, survivin, and tubulin polymerization. On the other hand, N ‐acylhydrazones (NAH) are known to be a very versatile motif in medicinal chemistry and drug design. Based on these data, we report in this paper, the synthesis of novel 3‐cyanopyridines incorporating N ‐acyl hydrazine scaffold, the evaluation of their cytotoxicity on the breast (MCF‐7) and ovarian (A‐2780) cancer cell lines and their antioxidant properties. Excluding 4a and 4d , all tested molecules exhibited high cytotoxicity against A‐2780, with IC 50 values ranging from 1.14 to 1.76 µM. Conversely, only four molecules 3d , 4b , 4c , and 4d demonstrated cytotoxicity against MCF‐7, with IC 50 values ranging from 1.14 to 3.38 µM. On the other hand, all the tested molecules exhibited a moderate antioxidant capacity in both the DPPH and metal chelation assays. Docking and molecular dynamics studies revealed that 2d , 3d , and 4d are potential inhibitors of tubulin and the œstrogen receptor, which may explain their high cytotoxicity. These results are promising to study these newly synthesized 3‐cyanopyridine‐N‐acylhydrazones in depth for use as potential anticancer candidates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Synthesis of Molecules with Biological Interest, University of Constantine 1, Constantine, Algeria.
- Physiology Department, Faculty of Medicine, Malatya Turgut Özal University, Malatya, Turkey.
- Physiology Department, Faculty of Medicine, İnönü University, Malatya, Turkey.
- Fundamental Sciences Laboratory, Amar Telidji University, Laghouat, Algeria.
- Laboratoire des sciences appliquées et didactiques, Ecole Normale Supérieure de Laghouat, Laghouat, Algeria.
- Basic Pharmaceutical Sciences Department, Faculty of Pharmacy, İnönü University, Malatya, Turkey.
ORCID-Profile: Fatümetüzzehra Küçükbay
Zitieren
APA
Kadi, I., Şekerci, G., Boulebd, H., Zebbiche, Z., Tekin, S., Benarous, K., Serseg, T., Küçükbay, F., Küçükbay, H., & Boumoud, T. (2024). Exploring the anticancer potential of new 3‐cyanopyridine derivatives bearing N‐acylhydrazone motif: Synthesis, DFT calculations, cytotoxic evaluation, molecular modeling, and antioxidant properties. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.23819
Vancouver
Kadi I, Şekerci G, Boulebd H, Zebbiche Z, Tekin S, Benarous K, et al. Exploring the anticancer potential of new 3‐cyanopyridine derivatives bearing N‐acylhydrazone motif: Synthesis, DFT calculations, cytotoxic evaluation, molecular modeling, and antioxidant properties. Journal of Biochemical and Molecular Toxicology. 2024. doi:10.1002/jbt.23819
BibTeX
@article{Kadi2024,
author = {Kadi, Ibtissem and Şekerci, Güldeniz and Boulebd, Houssem and Zebbiche, Zineddine and Tekin, Suat and Benarous, Khedidja and Serseg, Talia and Küçükbay, Fatümetüzzehra and Küçükbay, Hasan and Boumoud, Taoues},
title = {Exploring the anticancer potential of new 3‐cyanopyridine derivatives bearing N‐acylhydrazone motif: Synthesis, DFT calculations, cytotoxic evaluation, molecular modeling, and antioxidant properties},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2024},
doi = {10.1002/jbt.23819}
}
EUVIMED